Bristol-Myers Squibb - Princeton, NJ
posted 4 months ago
The Senior Director, Risk Management and Central Monitoring position at Bristol Myers Squibb is a pivotal role within the Clinical Oversight and Risk Management Leadership Team. This position is responsible for developing and implementing risk-based strategies that enhance the efficiency and effectiveness of clinical trials through comprehensive monitoring and data oversight. The Senior Director will work closely with various stakeholders to ensure alignment and buy-in for the Risk-Based Management (RBM) strategy, which is crucial for delivering reliable clinical trial information necessary for internal decision-making, regulatory approval, and market acceptance. The role emphasizes a holistic approach to quality by design, clinical trial risk management, and continuous improvement, ensuring that the organization operates at the highest standards of quality and compliance. In this role, the Senior Director will lead the Risk Management and Central Monitoring team, guiding them in executing the RBM framework and enhancing quality across clinical trials (Phases 1-4). The position requires a strategic mindset to drive the development of a comprehensive vision and roadmap for risk management capabilities, enabling proactive risk management and data insights that support BMS Drug Development's performance and the safety of trial participants. The Senior Director will also be responsible for monitoring the quality of Global Development Operations (GDO) activities, identifying risks, and collaborating with various functions to address any gaps. The Senior Director will engage with VP-level peers across the Drug Development organization to facilitate risk discussions at the portfolio level, ensuring that insights from the Risk Management and Central Monitoring team inform decision-making at multiple levels, including site, study, and country. This role also involves participating in industry forums to stay abreast of best practices in centralized monitoring and risk management, ensuring that BMS remains at the forefront of industry standards. The position is expected to be in the office 50% of the time over a two-week period, in accordance with company policy.